Natco Pharma

Pee Safe partially closes Series B round with $3 mn from Natco Pharma, Rainmatter Health

Read more

NATCO announces ANDA filing for generic olaparib tablets in US

Read more

Delhi HC rules in favour of Natco in patent infringement case

Read more

NATCO gets ANDA approval for Cabazitaxel Intravenous Solution

Read more

Natco Pharma plans to launch Molnupiravir capsules this week

Read more

Natco Pharma launches novel fixed-dose combination drug for colorectal, gastric cancer

Read more

Natco gets US FDA approval for Carfilzomib vials

Read more

Natco Pharma gets USFDA approval for lenalidomide capsules

Read more

Natco commences phase-III clinical trial of Molnupiravir for COVID-19 treatment

Read more

Government working to eliminate shortage of Amphotericin-B drug: Mansukh Mandaviya

Read more